title: Venous thromboembolism in amyotrophic lateral sclerosis: Should we consider routine prophylactic anticoagulation?
authors.affiliation: Royal Brisbane & Women's Hospital, University of Queensland Centre for Clinical Research.
authors.forename: Kimberley
authors.initials: K
authors.lastname: Forrest
authors.forename: Peter
authors.initials: P
authors.lastname: O'Rourke
authors.forename: Pamela
authors.initials: P
authors.lastname: McCombe
authors.forename: Robert
authors.initials: R
authors.lastname: Henderson
mesh_terms: D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069552:Rivaroxaban / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000150:complications / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban